3-噻吩甲酸4-(溴甲基)-甲酯 | 99708-92-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 中文名称: 3-噻吩甲酸4-(溴甲基)-甲酯
• 英文名称: methyl 4-(bromomethyl)thiophene-3-carboxylate
• CAS: 99708-92-6
• 化学式: C₇H₇BrO₂S
• 分子量: 235.101
• InChiKey: PBXNGBKSXDFEPZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  54.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-噻吩甲酸4-(溴甲基)-甲酯 在 氢氧化钾 、 sodium azide 、 氯甲酸乙酯 、 三乙胺 作用下， 以 甲醇 、 水 、 丙酮 为溶剂， 反应 26.25h， 生成 4-(2-Formyl-pyrrol-1-ylmethyl)-thiophene-3-carbonyl azide
  参考文献：
  名称：

  氮和硫杂环化合物的研究：10 H-吡咯并[1,2- a ]噻吩并[3,4- e ] [1,4]-二氮杂-5-5（4 H）-one及其一些衍生物的合成

  摘要：

  从甲基3-溴甲基噻吩-中描述了10 H-吡咯并[1,2- a ]噻吩并[3,4- e ] [1,4]二氮杂ze-5（4 H）-one（16）和一些衍生物的合成。 4-羧酸盐（5）。这些序列的关键步骤是羰基叠氮化物12和13的分子内环化。

  DOI：

  10.1002/jhet.5570310214
• 作为产物：
  描述：

  噻吩-3,4-二羧酸二甲酯 在 硼烷四氢呋喃络合物 、 四溴化碳 、 三苯基膦 、 sodium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 5.17h， 生成 3-噻吩甲酸4-(溴甲基)-甲酯
  参考文献：
  名称：

  Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase

  摘要：

  Two principal neurotransmitters are involved in the regulation of mammalian neuronal activity, namely, gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter, and L-glutamic acid, an excitatory neurotransmitter. Low GABA levels in the brain have been implicated in epilepsy and several other neurological diseases. Because of GABA's poor ability to cross the blood-brain barrier (BBB), a successful strategy to raise brain GABA concentrations is the use of a compound that does cross the BBB and inhibits or inactivates GABA aminotransferase (GABA-AT), the enzyme responsible for GABA catabolism. Vigabatrin, a mechanism-based inactivator of GABA-AT, is currently a successful therapeutic for epilepsy, but has harmful side effects, leaving a need for improved GABA-AT inactivators. Here, we report the synthesis and evaluation of a series of heteroaromatic GABA analogues as substrates of GABA-AT, which will be used as the basis for the design of novel enzyme inactivators. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2012.08.009

文献信息

• COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF
  申请人：BioTheryX, Inc.

  公开号：US20180170948A1

  公开（公告）日：2018-06-21

  The present invention provides compounds that modulate protein function, to restore protein homeostasis, including cytokine, CK1α, GSPT1, aiolos, and/or ikaros activity, and cell-cell adhesion. The invention provides methods of modulating protein-mediated diseases, such as cytokine-mediated diseases, disorders, conditions, or responses. Compositions, including in combination with other cytokine and inflammatory mediators, are provided. Methods of treatment, amelioration, or prevention of diseases, disorders, or conditions associated with a protein, such as diseases, disorders, and conditions associated with cytokines, including inflammation, fibromyalgia, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, inflammatory bowel diseases, Crohn's disease, ulcerative colitis, uveitis, inflammatory lung diseases, chronic obstructive pulmonary disease, Alzheimer's disease, and cancer, are provided.

  本发明提供了调节蛋白功能的化合物，以恢复蛋白稳态，包括细胞因子、CK1α、GSPT1、艾奥洛斯和/或伊卡洛斯活性和细胞间粘附。该发明提供了一种调节蛋白介导的疾病的方法，如细胞因子介导的疾病、障碍、状况或反应。提供了包括与其他细胞因子和炎症介质结合的组合物。提供了治疗、改善或预防与蛋白相关的疾病、障碍或状况的方法，包括与细胞因子相关的疾病、障碍和状况，包括炎症、纤维肌痛、类风湿性关节炎、骨关节炎、强直性脊柱炎、银屑病、银屑病关节炎、炎症性肠病、克罗恩病、溃疡性结肠炎、葡萄膜炎、炎症性肺病、慢性阻塞性肺病、阿尔茨海默病和癌症。
• Compounds targeting proteins, compositions, methods, and uses thereof
  申请人：BioTheryX, Inc.

  公开号：US10040804B2

  公开（公告）日：2018-08-07

  The present invention provides compounds that modulate protein function, to restore protein homeostasis, including cytokine, CK1α, GSPT1, aiolos, and/or ikaros activity, and cell-cell adhesion. The invention provides methods of modulating protein-mediated diseases, such as cytokine-mediated diseases, disorders, conditions, or responses. Compositions, including in combination with other cytokine and inflammatory mediators, are provided. Methods of treatment, amelioration, or prevention of diseases, disorders, or conditions associated with a protein, such as diseases, disorders, and conditions associated with cytokines, including inflammation, fibromyalgia, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, inflammatory bowel diseases, Crohn's disease, ulcerative colitis, uveitis, inflammatory lung diseases, chronic obstructive pulmonary disease, Alzheimer's disease, and cancer, are provided.

  本发明提供了调节蛋白质功能的化合物，以恢复蛋白质的平衡，包括细胞因子、CK1α、GSPT1、aiolos 和/或 ikaros 活性以及细胞-细胞粘附性。本发明提供了调节蛋白质介导的疾病，如细胞因子介导的疾病、失调、病症或反应的方法。本发明提供了组合物，包括与其他细胞因子和炎症介质的组合物。提供了治疗、改善或预防与蛋白质相关的疾病、失调或病症的方法，例如与细胞因子相关的疾病、失调和病症，包括炎症、纤维肌痛、类风湿性关节炎、骨关节炎、强直性脊柱炎、银屑病、银屑病关节炎、炎症性肠病、克罗恩病、溃疡性结肠炎、葡萄膜炎、炎症性肺病、慢性阻塞性肺病、阿尔茨海默病和癌症。
• A New Convenient Method For Preparation of Condensed Aromatic and Heterocyclic Thiolactones
  作者：Daniel Végh、Jean Morel、Bernard Decroix、Peter Zálupský

  DOI：10.1080/00397919208021340

  日期：1992.7

  Cyclocondensation of the benzylic-type thiols (Ib-VIb) in ortho position on aromatic and heteroaromatic carboxylic acids to form the corresponding thiolactones (Ic-VIc) can be effected with polyphosphate esters (PPE) in organic solvents in 75-90% yields.
• A new synthesis of benzo[b]thiophenes and benzo[c]thiophenes by annulation of disubstituted thiophenes
  作者：Jan W. Terpstra、Albert M. Van Leusen

  DOI：10.1021/jo00352a019

  日期：1986.1
• TERPSTRA, J. W.;VAN, LEUSEN, A. M., J. ORG. CHEM., 1986, 51, N 2, 230-238
  作者：TERPSTRA, J. W.、VAN, LEUSEN, A. M.

  DOI：——

  日期：——